 |
인쇄하기
취소
|
Re-evaluation of three ingredients to be planned within this year, KFDA says
The Korea Food and Drug Administration (KFDA) said recently it will re-evaluate the bioequivalence testing results of simvastatin, felodipine and itraconazol within this year,
which was originally planned in 2008
The KFDA announcement came after Korean Medical Association (KMA) claimed that their independent bio-equivalence tests, conducted on five generic drugs from five different pharmac...
which was originally planned in 2008
The KFDA announcement came after Korean Medical Association (KMA) claimed that their independent bio-equivalence tests, conducted on five generic drugs from five different pharmac...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.